Schedule 13G ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-20-001128
- Form type
- SC 13G
- Filer
- Broadfin Capital, LLC
- CIK
- CIK 1511901
- Filed
- Feb 13, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership